- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 128M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 128.2M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 130.3M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 130.6M sh |
| Shares Outstanding | Q3 2026 · Mar 31, 2026 | 126.09M sh |
| Stock Repurchased | Q3 2026 · Mar 31, 2026 | $1.01B |
| Stock Repurchased restated | Q3 2026 · Mar 31, 2025 | $860M |
| Dividends Paid | Q3 2026 · Mar 31, 2026 | $683M |
| Dividends Paid restated | Q3 2026 · Mar 31, 2025 | $630M |
| Capex | Q3 2026 · Mar 31, 2026 | $286M |
| Capex restated | Q3 2026 · Mar 31, 2025 | $304M |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $2.63B |
| Operating Cash Flow restated | Q3 2026 · Mar 31, 2025 | $2.31B |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $476M |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $467M |
| Stockholders Equity | Q3 2026 · Mar 31, 2026 | $14.61B |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $13.68B |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $6.74B |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $5.82B |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $16.06B |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $15.8B |
| Current Assets | Q3 2026 · Mar 31, 2026 | $7.61B |
| Current Assets | Q3 2026 · Jun 30, 2025 | $6.95B |
| Total Assets | Q3 2026 · Mar 31, 2026 | $30.68B |
| Total Assets | Q3 2026 · Jun 30, 2025 | $29.49B |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $7.06 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | $19.95 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $7.37 |
| Eps Diluted | Q3 2026 · Mar 31, 2025 | $19.97 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $7.16 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | $20.24 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $7.48 |
| Eps Basic | Q3 2026 · Mar 31, 2025 | $20.28 |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $884M |
| Sga Expense | Q3 2026 · Mar 31, 2026 | $2.59B |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $785M |
| Sga Expense restated | Q3 2026 · Mar 31, 2025 | $2.42B |
| Operating Income | Q3 2026 · Mar 31, 2026 | $1.23B |
| Operating Income | Q3 2026 · Mar 31, 2026 | $3.59B |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | $1.11B |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | $3.16B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $3.47B |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $9.89B |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $3.13B |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $9.25B |
| Revenue | Q3 2026 · Mar 31, 2026 | $5.49B |
| Revenue | Q3 2026 · Mar 31, 2026 | $15.74B |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $4.96B |
| Revenue restated | Q3 2026 · Mar 31, 2025 | $14.61B |